Overbooked euroPLX Closes Ten Days Before Registration Deadline

Dielheim/Heidelberg, Germany, 30 January 2009: Ten days before the official registration deadline on February 9, 2009, the pharma partnering conference euroPLX 39 Lisbon was overbooked by 25% over the maximum acceptable number of registered companies and is now closed for registration.

Registrations received between closure and February 9 will not be accepted but all rejected registrants will be compensated with a substantial discount towards one of the next euroPLX Meetings in 2009.

Now in its 15th year, euroPLX Meetings are regular partnering events, attended by top-level business development executives from all over the world to discuss and negotiate pharma deals in a highly organised process.

Company owners or their family members, Chief Executive Officers, Managing Directors, Presidents, and Vice Presidents usually make up a third of the participants of euroPLX Meetings. Directors and Heads of Business Development constitute another third. The decision power present is underscored by the size of the deals: some companies have initiated their largest deals ever at euroPLX® (short for European Pharma License Exchange).

euroPLX Meetings typically deliver an average of 23-24 pre-scheduled business negotiations per company, far above the mainstream partnering conference standard. They are smaller, more focused, and more affordable.

Media Contact:
RauCon business development
Kurfurstenstr 1A
69234 Dielhem, Germany
Dr. Norbert Rau at +49 6222 980 711; nr@raucon.com